Trial Profile
Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2011
Price :
$35
*
At a glance
- Drugs Entacapone; Rasagiline
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Acronyms LARGO
- 05 Nov 2010 New trial record.